---
title: "Sichuan Huiyu Pharmaceutical Secures Overseas Market Approvals for Key Products"
date: "2025-02-11 15:13:59"
summary: "Sichuan Huiyu Pharmaceutical received market approvals in the Netherlands, Costa Rica, Peru and Pakistan for four cancer and autoimmune disease treatments. Cyclophosphamide for injection obtained market approval for Netherlands, irinotecan hydrochloride injection for Costa Rica, plerixafor injection for Peru and fulvestrant injection for Pakistan, according to a Tuesday filing with..."
categories:
  - "MT Newswires"
lang:
  - "en"
translations:
  - "en"
tags:
  - "MT Newswires"
menu: ""
thumbnail: ""
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

Sichuan Huiyu Pharmaceutical received market approvals in the Netherlands, Costa Rica, Peru and Pakistan for four cancer and autoimmune disease treatments.

Cyclophosphamide for injection obtained market approval for Netherlands, irinotecan hydrochloride injection for Costa Rica, plerixafor injection for Peru and fulvestrant injection for Pakistan, according to a Tuesday filing with the Shanghai bourse.

Shares of the company were down less than 1% Tuesday.

[MT Newswires](https://www.tradingview.com/news/mtnewswires.com:20250211:G2466147:0/)
